A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 - but only if between two and ...

Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.

The Trump administration this week decimated HIV prevention programs across government health agencies after terminating ...

HIV outbreak in Kerala sparks fear and stigma among injecting drug users, prompting urgent response from health authorities.

The majority of men also admit to never having tested for HIV, despite over a third (37%) having regular unprotected sex. Of ...

If all is good, then why do we need new options? Yes, HIV treatment – daily oral regimen – is lifesaving and good – access to ...

HIV myths cause fear and stigma. Get the facts on transmission, prevention, and treatment to protect yourself and others.

If funding cuts continue, the world could face higher rates of annual new HIV infections by 2030 than at the peak of the ...

The CDC's potential 'streamlining' of programs to prevent HIV has two Southern California health agencies worried the ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

Early HIV detection can mean the difference between a long, healthy life and severe complications. Learn why timing matters ...